Retatrutide showing promise in obesity (and type 2 diabetes)

Doggrell, SA

Doggrell, SA (通讯作者),Griffith Univ, Sch Pharm & Med Sci, Gold Coast Campus, Southport, Qld, Australia.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023; 32 (11): 997

Abstract

Introduction: Obesity is a major risk factor for cardiovascular disease, diabetes, osteoarthritis, and some cancers. Retatrutide stimulates Glucagon-l......

Full Text Link